NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study

Table 3

Relationship between Log NT-ProBNP and MACE in different models.

Variable	Nonadjusted^1 (β, 95% CI, value)	Adjusted I (β, 95% CI, value)	Adjusted II (β, 95% CI, value)
Log NT-proBNP (pg/mL)	1.63 (1.40, 1.89, <0.0001)	1.60 (1.37, 1.86, <0.0001)	1.50 (1.26, 1.78, <0.0001)
Log NT-proBNP (pg/mL) (quartile)
T1	1.0	1.0	1.0
T2	1.55 (0.84, 2.88, 0.1636)	1.53 (0.82, 2.85, 0.1793)	1.24 (0.63, 2.46, 0.5390)
T3	4.75 (2.67, 8.44, <0.0001)	4.38 (2.42, 7.93, <0.0001)	3.31 (1.69, 6.48, 0.0005)
P For trend	<0.0001	<0.0001	<0.0001

¹Nonadjusted model. Adjusted model I: adjusted for age and sex. Adjusted model II: adjusted for age, sex, number of implanted stents, number of the used balloons, pre-PCI TIMI grade, hypertension, hyperlipidemia, diabetes, smoking, time from admission to balloon dilatation, Killip class, post-PCI TIMI grade, and TIMI risk score.